CIK 0001583648
- Non-accelerated filer
- Smaller reporting company
PALVELLA THERAPEUTICS, INC.
Sign in to watch- Ticker
- PVLA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 300784346
- Phone
- +1 484-253-1461
- Business address
- 353 W. LANCASTER AVENUE, SUITE 200, WAYNE, PA, 19087
- Former names
- PIERIS PHARMACEUTICALS, INC., Marika Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,071,070
- in 6 filings, $11.0M under 10b5-1 plans
Net −$11,071,070. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-21 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-06-22 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2021-06-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2020-06-23 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2020-01-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +5,431 | $2.11 | $11K | 5,431 |
| 2020-01-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2019-10-25 | Richman Michael Director | Grant or award · Stock Options (right to buy) | +5,165 | $2.12 | $11K | 5,165 |
| 2019-07-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +3,789 | $2.89 | $11K | 3,789 |
| 2019-04-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +5,640 | $1.94 | $11K | 5,640 |
| 2019-01-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +6,096 | $1.79 | $11K | 6,096 |
| 2019-01-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2018-10-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +3,829 | $2.86 | $11K | 3,829 |
| 2018-07-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +2,837 | $3.86 | $11K | 2,837 |
| 2018-04-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +2,665 | $4.10 | $11K | 2,665 |
| 2018-01-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +2,243 | $5.09 | $11K | 2,243 |
| 2018-01-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2017-10-25 | Richman Michael Director | Grant or award · Stock Option (Rights to buy) | +4,006 | 4,006 | ||
| 2017-07-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +3,288 | 3,288 | ||
| 2017-04-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +7,821 | 7,821 | ||
| 2017-01-25 | Richman Michael Director | Grant or award · Stock Option (right to buy) | +9,687 | 9,687 |
Page 1 of 2 · 25 trades